Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) EBT Margin (2020 - 2026)

Treace Medical Concepts filings provide 6 years of EBT Margin readings, the most recent being 10.79% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 989.0% to 10.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 26.66%, a 12.0% increase, with the full-year FY2025 number at 26.66%, up 12.0% from a year prior.
  • EBT Margin hit 10.79% in Q4 2025 for Treace Medical Concepts, up from 32.62% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 0.9% in Q4 2024 to a low of 47.95% in Q2 2024.
  • Median EBT Margin over the past 5 years was 30.82% (2022), compared with a mean of 27.55%.
  • Biggest five-year swings in EBT Margin: tumbled -3045bps in 2021 and later soared 1306bps in 2023.
  • Treace Medical Concepts' EBT Margin stood at 19.8% in 2021, then soared by 59bps to 8.15% in 2022, then dropped by -26bps to 10.25% in 2023, then soared by 91bps to 0.9% in 2024, then plummeted by -1098bps to 10.79% in 2025.
  • The last three reported values for EBT Margin were 10.79% (Q4 2025), 32.62% (Q3 2025), and 36.97% (Q2 2025) per Business Quant data.